Drugs / IC2000
IC2000
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03200704 | Jan 2019 → Aug 2020 | breast cancer | Novadaq Technologies ULC | Completed | Met primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IC2000 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03200704 ↗ |
| Known as | ICG | “IC2000 (Indocyanine Green (ICG) for Injection)” NCT03200704 ↗ |
| Known as | Indocyanine Green | “IC2000 (Indocyanine Green (ICG) for Injection)” NCT03200704 ↗ |
| Modality | Diagnostic / imaging agent | “as an intraoperative fluorescence visualization tool” NCT03200704 ↗ |